Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(quinoxalin-6-ylcarbonyl)piperidine
2. Bdp 12
3. Bdp-12
4. Cx516
1. 154235-83-3
2. Piperidin-1-yl(quinoxalin-6-yl)methanone
3. Cx-516
4. Cx516
5. Bdp 12
6. 1-(quinoxalin-6-ylcarbonyl)piperidine
7. 1-(6-quinoxalinylcarbonyl)piperidine
8. Bdp-12
9. Cx 516
10. Abt-224
11. Piperidine, 1-(6-quinoxalinylcarbonyl)-
12. 6-(piperidine-1-carbonyl)quinoxaline
13. 1-piperidyl(quinoxalin-6-yl)methanone
14. Chembl136800
15. Z5qu38b4v9
16. 173047-75-1
17. Chebi:34605
18. 287399-47-7
19. 1-(quinoxalin-6-ylcarbonyl)-piperidine
20. Piperidin-1-yl-quinoxalin-6-yl-methanone
21. Unii-z5qu38b4v9
22. Spd-420
23. Ampakine Cx516
24. 1-piperidinyl-6-quinoxalinylmethanone
25. Ampalex-[d10]
26. Bdp-12(ampalex)
27. Ampalex (cx-516)
28. Ampalex, Cx-516
29. Schembl194605
30. Gtpl4165
31. Zinc6489
32. Ampalex I(1/4)oecx-516
33. Dtxsid70165574
34. Ex-a265
35. Amy14816
36. Bcp04606
37. Ac-001
38. Bdbm50094009
39. Mfcd00943201
40. Akos008927689
41. 1-piperidinyl-6-quinoxalinyl-methanone
42. Bcp9000296
43. Cs-1086
44. Db06247
45. Ds-1548
46. Fs-3368
47. 6-[(piperidin-1-yl)carbonyl]quinoxaline
48. Ncgc00371146-01
49. Cx516, >=98% (hplc)
50. Hy-10933
51. Bcp0726000046
52. Ft-0657266
53. Vu0430675-1
54. 235a833
55. J-009084
56. Q5014875
57. Cx5
Molecular Weight | 241.29 g/mol |
---|---|
Molecular Formula | C14H15N3O |
XLogP3 | 1.8 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 1 |
Exact Mass | 241.121512110 g/mol |
Monoisotopic Mass | 241.121512110 g/mol |
Topological Polar Surface Area | 46.1 Ų |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 301 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in alzheimer's disease, memory loss, autism, neurologic disorders, dementia, schizophrenia and schizoaffective disorders, attention deficit/hyperactivity disorder (ADHD), and sleep disorders.
CX 516 is a benzylpiperidine AMPAkine, an AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) modulator, that enhances the function of glutamate when it binds allosterically to the AMPA receptor channel complex. CX 516 slows receptor deactivation with a longer open time, slower excitatory postsynaptic potential (EPSP) decay and improvement of hippocampal long term potentiation (LTP).
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?